Balaxi Healthcare Honduras has consequently become the Step-down subsidiary of Balaxi Pharmaceuticals. BHH is engaged in Balaxi’s pharmaceutical formulation products in Honduras. The acquisition was completed on May 11, 2021 and the cost of acquisition was USD 10,000.
At around 12.12 pm, Balaxi Pharmaceuticals Limited was trading at Rs580.35 per piece up Rs2.55or 0.44% on the BSE. It touched an intraday high of Rs589.90 per piece on Wednesday.